Get started
Author

Erika Meli

Impact of treatment‐related liver toxicity on the outcome of HCV‐positive non‐Hodgkin's lymphomas
2009 · Luca Arcaini, Michele Merli, et al. · American Journal of Hematology · 59
Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi ( FIL )
2019 · Chiara Rusconi, Antonella Anastasia, et al. · British Journal of Haematology · 32
PDF
The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of Pet-guided treatments
2019 · Fondazione Italiana Linfomi (Onlus), Alessia Bari, et al. · Annals of Hematology · 18
PDF
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi
2023 · Manuel Gotti, Roberta Sciarra, et al. · HemaSphere · 13
RE-MIND study: A propensity score-based 1:1 matched comparison of tafasitamab + lenalidomide (L-MIND) versus lenalidomide monotherapy (real-world data) in transplant-ineligible patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
2020 · Grzegorz S. Nowakowski, Thomas David Rodgers, et al. · Journal of Clinical Oncology · 12
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi
2023 · Gloria Margiotta-Casaluci, Sara Bigliardi, et al. · Frontiers in Oncology · 6
PDF
Anti-CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the R-FolSTOP multicentre Italian study
2025 · Alessia Castellino, Lorenzo Comba, et al. · Annals of Hematology · 3
Management of vaccinations in patients with non‐Hodgkin lymphoma
2024 · Michele Merli, Andrea Costantini, et al. · British Journal of Haematology · 3
PDF
Current Treatment Options and the Role of Functional Status Assessment in Classical Hodgkin Lymphoma in Older Adults: A Review
2023 · Vittorio Ruggero Zilioli, Cristina Muzi, et al. · Cancers · 3
PDF
Safety and Efficacy of Netupitant/Palonosetron and Dexamethasone in Classical Hodgkin’s Lymphoma Patients with Inadequate Chemotherapy-Induced Nausea and Vomiting Prophylaxis with Palonosetron and Dexamethasone: A Single-Center Real-Life Experience
2020 · Vittorio R Zilioli, Cristina Muzi, et al. · International Journal of Hematologic Oncology · 3
Outcome of Transformed Marginal Zone Lymphomas Treated in the Rituximab Era
2015 · Chiara Rusconi, Maria Luisa Guerrera, et al. · Blood · 3
ABCL-135: RE-MIND: A Comparison of Tafasitamab (MOR208) + Lenalidomide (L-MIND) Versus Lenalidomide Monotherapy (Real-World Data) in Transplant-Ineligible Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
2020 · Thomas Rodgers, Pier Luigi Zinzani, et al. · Clinical Lymphoma Myeloma & Leukemia · 2
Rituximab Plus Bortezomib Still Represents an Effective Treatment Option for Patients with Relapsed or Refractory Mantle Cell Lymphoma
2017 · Vittorio Ruggero Zilioli, Cristina Gabutti, et al. · BOA (University of Milano-Bicocca) · 2
Role of Positron Emission Tomography In Mantle Cell Lymphoma
2010 · Chiara Rusconi, Cristina Gabutti, et al. · Blood · 2
Decisional Role of Interim PET in Relapsed/Refractory Classical Hodgkin Lymphoma Treated with Begev Chemotherapy As First Salvage
2022 · Chiara Rusconi, Francesca Ricci, et al. · Blood · 1
FDG-Positron Emission Tomography in T-Cell Lymphoma
2011 · Chiara Rusconi, Cristina Gabutti, et al. · Blood · 1
RENOIR phase 3 rituximab-lenalidomide vs rituximab as maintenance treatment in relapsed/refractory follicular lymphoma
2026 · Barbara Botto, Carola Boccomini, et al. · Blood Advances
Primary Cardiac Lymphoma: A Rare Case of Classical Hodgkin Lymphoma
2026 · Cristina Muzi, Vittorio Ruggero Zilioli, et al. · Annals of Case Reports
PDF
690 | the Prognostic Role of Ebv in Post‐transplant Lymphoproliferative Disorders: a Retrospective Single Center Analysis
2025 · P. Minga, F. Colombo, et al. · Hematological Oncology
PDF
Correction to: Anti CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the RFolSTOP multicentre Italian study
2025 · Alessia Castellino, Lorenzo Comba, et al. · Annals of Hematology
PDF
Fertility preservation in lymphoma patients treated with immunochemotherapy regimens with or without radiotherapy: results of a retrospective multicenter Italian study (Ferty care)
2024 · Ombretta Annibali, Alessia Castellino, et al. · Leukemia & lymphoma/Leukemia and lymphoma
Survival of Hodgkin Lymphoma Patients Treated with Novel Immunotherapies after Autologous Stem Cell Transplantation Failure: A Retrospective Analysis of the Italian Lymphoma Foundation (FIL)
2023 · Maura Nicolosi, Valentina Bozzoli, et al. · Blood
PDF
Supplementary Data from RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a Real-world Lenalidomide Monotherapy Cohort in Relapsed or Refractory Diffuse Large B-cell Lymphoma
2023 · Pier Luigi Zinzani, Thomas Rodgers, et al.
Supplementary Data from RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a Real-world Lenalidomide Monotherapy Cohort in Relapsed or Refractory Diffuse Large B-cell Lymphoma
2023 · Pier Luigi Zinzani, Thomas Rodgers, et al.
Data from RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a Real-world Lenalidomide Monotherapy Cohort in Relapsed or Refractory Diffuse Large B-cell Lymphoma
2023 · Pier Luigi Zinzani, Thomas Rodgers, et al.
Works count: 35
Citation count: 163
H-index: 6
I10-index: 5
Year
Topic
Type